Future of town's Pride event ‘hangs in balance' amid rising costs and donations drop
Scarborough's celebration of the town's LGBT+ community is at risk of closure, with organisers now launching a fundraising campaign aiming to secure it long-term.
George Wakely, chair of the Scarborough Pride charity, said its flagship event on the North Yorkshire coast has 'blossomed into a joyous, defiant, and inclusive celebration of identity, love, and equality', adding: 'It's a lifeline for many – a beacon of visibility, solidarity, and support.'
But Mr Wakely said a drop in donations means the charity 'can't pay for the minimum we need to put the event on before we factor in performers'.
McCain Foods has sponsored previous Scarborough Prides but the volunteer run charity said donations have 'traditionally underpinned the event'.
Read next: 'We just want to exist in peace': Thousands turn out for York Pride 2025
These donations, however, have 'dropped significantly in recent months', a charity spokesperson said.
They added: 'Without a strong financial backbone, Scarborough Pride may not return next year.'
Mr Wakley has called on the local community to support the future of the event.
'Scarborough Pride has always been about community, about showing up for each other, being visible, and celebrating freedom in all its forms,' the charity spokesperson said. 'Today, the community needs to show up for Pride.'
To support Scarborough Pride, visit its JustGiving Page titled 'Scarborough Pride'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic
-- GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review application for gepotidacin, an oral antibiotic aimed at treating sexually transmitted uncomplicated gonorrhoea. The drugmaker's shares climbed 1% in London on the news. The company is looking to new infectious disease products, including its recently launched respiratory syncytial virus vaccine, to offset expected revenue declines from top-selling medicines and looming patent expirations in its HIV portfolio. Gepotidacin is already approved in the U.S. under the brand name Blujepa for treating a common urinary tract infection in women and adolescent girls. The FDA is expected to decide in December on its use for uncomplicated urogenital gonorrhoea, which could offer patients an oral alternative to existing injectable treatments. Separately, GSK and Germany's CureVac last week resolved a long-running patent dispute with Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) over mRNA vaccine technology used during the COVID-19 pandemic. The settlement follows BioNTech's June agreement to acquire CureVac in an all-stock deal worth $1.25 billion to advance work on mRNA-based cancer therapies. Under the settlement, CureVac and GSK will receive $740 million and single-digit percentage royalties on future U.S. sales of COVID-19 vaccines, CureVac said. GSK's share amounts to $370 million, including $50 million to adjust terms from a 2024 licence agreement that expanded their pandemic-era partnership. If BioNTech's takeover of CureVac is completed, related mRNA litigation outside the U.S. will also be resolved, with GSK receiving an additional $130 million and royalties extended to non-U.S. sales. CureVac said the acquisition remains on track under the agreed terms. GSK said it still has separate patent cases against Pfizer and BioNTech in the U.S. and Europe, which are unaffected by this settlement. Related articles GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic USPS blocks major vape distributor over unregulated product shipments - Reuters Exclusive: Opendoor CEO Wheeler breaks silence, EMJ's Eric Jackson calls for more Sign in to access your portfolio
Associated Press
10 minutes ago
- Associated Press
Trados Launches AI-Powered Project Intelligence
MAIDENHEAD, England--(BUSINESS WIRE)--Aug 11, 2025-- RWS, a content solutions company, powered by technology and human expertise, announces the launch of Smart Insights – a new feature within its cloud-based Trados language technology platform that redefines how localization professionals manage global content at scale. Localization projects can be unpredictable. Deadlines shift, resources change, and priorities evolve. Smart Insights is an industry-first, LLM-powered virtual assistant within Trados that helps project managers navigate these complexities by answering everyday questions in plain language – like: 'Smart Insights changes the game for localization,' said Mark Lawyer, President of Regulated Industries & Linguistic AI at RWS. 'We're putting real-time project intelligence directly in the hands of the people who need it. No dashboards, no delays, just instant answers.' Smart Insights, powered by Amazon Q in QuickSight, is now included as part of the Trados Enterprise subscription giving Enterprise customers immediate access to advanced project visibility and control. For Trados Team and Trados Accelerate customers, Smart Insights is available as an optional upgrade, ensuring that businesses of all sizes can benefit from this powerful feature. Read our blog to learn more about Smart Insights. About us RWS is a content solutions company, powered by technology and human expertise. We grow the value of ideas, data and content by making sure organizations are understood. Everywhere. Our proprietary technology, 45+ AI patents and human experts help organizations bring ideas to market faster, build deeper relationships across borders and cultures, and enter new markets with confidence – growing their business and connecting them to a world of opportunities. It's why over 80 of the world's top 100 brands trust RWS to drive innovation, inform decisions and shape brand experiences. With 60+ global locations, across five continents, our teams work with businesses across almost all industries. Innovating since 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). More information: View source version on CONTACT: RWS Denis Davies Corporate Communications [email protected] +44 1628 410105 KEYWORD: EUROPE IRELAND UNITED KINGDOM INDUSTRY KEYWORD: SOFTWARE TECHNOLOGY ARTIFICIAL INTELLIGENCE DATA MANAGEMENT SOURCE: RWS Copyright Business Wire 2025. PUB: 08/11/2025 04:01 AM/DISC: 08/11/2025 04:01 AM
Associated Press
37 minutes ago
- Associated Press
Selwood Asset Management Statement on Progress at Canal+ and Hachette
LONDON--(BUSINESS WIRE)--Aug 11, 2025-- Karim Moussalem, CIO (Equities) at Selwood Asset Management, has praised management at both Canal+ SA (CAN) and Louis Hachette Group SA (ALHG) for the pace of progress in engaging with investors and providing evidence of their commitment to long-term value creation, but has urged both companies to do more. Since Mr. Moussalem's initial communication on April 9 about the underperformance of the companies, LHG's share price has rallied an impressive 29%, while Canal+ has surged by 58%*, reflecting the significant value being unlocked by both companies. This strong upward momentum is underpinned by their robust free cash flow generation and accelerating revenue growth, which stand as testaments to operational excellence and the inherent strength of their underlying business models. Today Mr. Moussalem has urged the managements of both companies, especially LHG, to engage more closely with investors. Selwood owns about 1.5% of the free float of LHG and just under 1% of its capital, while the Canal + holding is just over 0.5% of both the float and the capital. Mr. Moussalem said: 'With LHG, we have only very recently observed a tangible shift toward increased openness with investors and the market—a very welcome development. We encourage the company to build on these initial steps by providing greater clarity on operational targets, especially around Free Cash Flow (FCF) and Earnings Before Interest & Tax (EBIT) margin expectations once the ongoing restructuring of the travel retail and publishing divisions is finalised.' Mr. Moussalem observed that recent discussions with LHG management have confirmed that the current gun jumping procedures involving Vivendi do not preclude the potential merger between Lagardere and LHG. He said: 'We strongly believe that management should prioritise collapsing the dual-entity structure at the earliest opportunity. Upgrading LHG's listing from Euronext Growth to a higher market segment would not only enhance visibility but could also, by our estimates, generate close to 30 million shares of passive demand, further supporting valuation re-rating.' 'We believe LHG shares currently bear a triple-layered discount: first, relative to what we view as Lagardere's intrinsic fair value—which exceeds the Vivendi offer price of €24.10 from 2022; second, given that the Vivendi offer itself represented a premium to today's share price of approximately €20.50; and third, since that current price is still above the implied value reflected in LHG's own share price.' Turning to Canal+, Mr. Moussalem noted its proactive engagement with the market. 'The company's transparent communication, consistent delivery of updates, and effective execution of roadshows have played a pivotal role in restoring investor confidence and turbocharging the share price rally,' he said. In summary, the pace of progress at both Canal+ and LHG is evidence of their commitment to long-term value creation. 'We urge both management teams, and especially LHG, to accelerate their positive momentum by intensifying market communications and providing more detailed medium-term financial targets. This will be instrumental in attracting a broader investor base and fully unlocking the latent value in their shares,' Mr. Moussalem said. *Performance of CAN and ALHG to August 8, 2025 View source version on CONTACT: Media contactLondon Bill McIntosh Peregrine Communications Group T: +44 (0)79 7070 8715 [email protected] York Darius Athill Peregrine Communications T: + 1 917 970 8834 [email protected] KEYWORD: EUROPE IRELAND UNITED KINGDOM INDUSTRY KEYWORD: BANKING ASSET MANAGEMENT PROFESSIONAL SERVICES FINANCE SOURCE: Selwood Asset Management Copyright Business Wire 2025. PUB: 08/11/2025 04:00 AM/DISC: 08/11/2025 04:00 AM
